Mahadevappa, R.; Neves, H.; Yuen, S.M.; Jameel, M.; Bai, Y.; Yuen, H.-F.; Zhang, S.-D.; Zhu, Y.; Lin, Y.; Kwok, H.F.
DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast Cancer. Cancers 2018, 10, 282.
https://doi.org/10.3390/cancers10090282
AMA Style
Mahadevappa R, Neves H, Yuen SM, Jameel M, Bai Y, Yuen H-F, Zhang S-D, Zhu Y, Lin Y, Kwok HF.
DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast Cancer. Cancers. 2018; 10(9):282.
https://doi.org/10.3390/cancers10090282
Chicago/Turabian Style
Mahadevappa, Ravikiran, Henrique Neves, Shun Ming Yuen, Muhammad Jameel, Yuchen Bai, Hiu-Fung Yuen, Shu-Dong Zhang, Youzhi Zhu, Yao Lin, and Hang Fai Kwok.
2018. "DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast Cancer" Cancers 10, no. 9: 282.
https://doi.org/10.3390/cancers10090282
APA Style
Mahadevappa, R., Neves, H., Yuen, S. M., Jameel, M., Bai, Y., Yuen, H. -F., Zhang, S. -D., Zhu, Y., Lin, Y., & Kwok, H. F.
(2018). DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast Cancer. Cancers, 10(9), 282.
https://doi.org/10.3390/cancers10090282